DIFFERENTIATED APPROACH TO TREATMENT OF OSTEOARTHROSIS IN CARDIOVASCULAR PATHOLOGY

Aim. Assessment of clinical efficacy of cutaneous and supravenal cutaneous lowintensive radiation (CLIR) together with parenteral chondroitin sulfate (Chondrogard® ) in osteoarthrosis patients with cardiovascular comorbidities.Material and methods. Totally, 65 women and 15 men studied, at the age 50,62±8,9 y.o., with knee and hip osteoarthrosis stage I-III by X-ray staging. Patients from treatment group underwent intramuscular Chondrogard® once in 2 days for 2 months, with CLIR, cutaneous and supravenal, and low doses of NSAIDs. Controls received Chondrogard® with common therapy (CT) or only CT.Results. The significantly better dynamics is shown of the pain syndrome in joint is shown by the results of VAS in points and mm, and BP and HR, comparing to those receiving Chondrogard® and CT, that made to decrease the dosages of NSAIDs and to minimize side effects.